Ex Parte McElroy et al - Page 8




         Appeal No. 2003-0936                                                       
         Application No. 09/532,806                                                 


         examiner argues that “Claim 1 encompasses every subfragment of SEQ         
         ID NO:1 that is between 95 and 3536 contiguous bases long and that         
         has promoter function” (EA 5; emphasis added).  According to the           
         examiner, “the description must allow those skilled in the art to          
         recognize what regions of SEQ ID NO:1 would need to be retained in         
         its subfragments such that the subfragments could reasonably be            
         expected to retain promoter function” (EA 6).                              
              As we understand the rejection, the examiner concedes that            
         appellants’ specification describes every subfragment claimed which        
         can function as a promoter.  However, that description does not            
         satisfy the written description requirement of 35 U.S.C. § 112,            
         first paragraph, because the subfragments of SEQ ID NO:1 between           
         95 and 3536 contiguous bases in length that can function as a              
         promoter are not distinguished from the subfragments of SEQ ID NO:1        
         between 95 and 3536 contiguous bases in length that cannot function        
         as a promoter.  The problem with the examiner’s position is that it        
         confuses the written description requirement of 35 U.S.C. § 112,           
         first paragraph, with the enablement requirement of 35 U.S.C.              
         § 112, first paragraph.  For example, in support of the written            
         description requirement of 35 U.S.C. § 112, first paragraph, the           
         examiner states (EA 5-6)(emphasis added):                                  


                                         8                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007